These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13355037)

  • 1. [Systemic amyloidosis, associated with multiple myeloma].
    DEGOS R
    Ann Dermatol Syphiligr (Paris); 1956; 83(4):361-8. PubMed ID: 13355037
    [No Abstract]   [Full Text] [Related]  

  • 2. "Primary" systemic amyloidosis and myeloma.
    JAMA; 1961 Mar; 175():1098. PubMed ID: 14447245
    [No Abstract]   [Full Text] [Related]  

  • 3. "Primary" systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases.
    KYLE RA; BAYRD ED
    Arch Intern Med; 1961 Mar; 107():344-53. PubMed ID: 13755566
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
    Elgouhari H; Ahmed K; Niazi M; Huntington MK
    S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periorbital xanthoma-like amyloidosis in a patient with multiple myeloma-associated systemic amyloidosis.
    Kikuchi N; Ohashi T; Yamamoto T
    Eur J Dermatol; 2019 Oct; 29(5):566-567. PubMed ID: 31789281
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple myeloma presenting with acquired cutis laxa and primary systemic amyloidosis.
    Lee MY; Byun JY; Choi YW; Choi HY
    Eur J Dermatol; 2017 Dec; 27(6):654-655. PubMed ID: 29311044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Paramyloidosis in multiple plasma cell myeloma].
    KARPISEK J; VALACH V; WOLF J
    Cas Lek Cesk; 1954 Oct; 93(42):1172-8. PubMed ID: 13219683
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin light chain amyloidosis associated with multiple myeloma in a young patient: a case report.
    Morais OO; Costa LO; Shinzato DH; Hans-Filho G
    West Indian Med J; 2010 Mar; 59(2):219-21. PubMed ID: 21275130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary amyloidosis associated with multiple myeloma and renal failure: case report].
    Peña O C; Intriago B M; Gray H AM; Cabrera C ME
    Rev Med Chil; 2011 Nov; 139(11):1471-4. PubMed ID: 22446653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systematized amyloidosis of the tongue, associated with a multiple myeloma of the bones (Kahler's disease)].
    DEGOS R; GARNIER G; OSSIPOWSKI B; BOUTET R; PERNOT JM
    Bull Soc Fr Dermatol Syphiligr; 1955; (3):291-3. PubMed ID: 13270040
    [No Abstract]   [Full Text] [Related]  

  • 11. Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis.
    Debski J; Usnarska-Zubkiewicz L; Kapelko-Słowik K; Pawluś A; Zaleska-Dorobisz U; Kuliczkowski K
    Turk J Haematol; 2018 Mar; 35(1):71-72. PubMed ID: 27531413
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
    Rutten KHG; Raymakers RAP; Minnema MC
    Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneo-mucosal amyloidosis and myeloma].
    DUGOIS P; CHATARD H; HOLLARD D
    Bull Soc Fr Dermatol Syphiligr; 1962; 69():145-7. PubMed ID: 13888270
    [No Abstract]   [Full Text] [Related]  

  • 14. Raccoon eyes in systemic AL amyloidosis.
    Nicholson JA; Tappin J
    Br J Haematol; 2011 Jun; 153(5):543. PubMed ID: 21477158
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
    Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
    Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary systemic amyloidosis associated with multiple myeloma: a case report and review of the literature.
    Mason AR; Rackoff EM; Pollack RB
    Cutis; 2007 Sep; 80(3):193-200. PubMed ID: 17956007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloidosis in malignant plasmocytic diseases: paramyloidosis].
    FRUHLING L; KEMPF J; CHADLI A
    Ann Anat Pathol (Paris); 1962; 7():87-117. PubMed ID: 13895571
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
    Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
    Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.